Search

Scabies, caused by the Sarcoptes scabiei var hominis mite burrowing into the skin, is a highly contagious disease characterized by intense nocturnal itching. Its global impact is considerable, affecting more than 200 million individuals annually and posing significant challenges to healthcare systems worldwide. Transmission occurs primarily through direct skin‐to‐skin contact, contributing to its widespread prevalence and emergence as a substantial public health concern affecting large populations. This review presents consensus‐based clinical practice guidelines for diagnosing and managing scabies, developed through the fuzzy Delphi method by dermatology, parasitology, pediatrics, pharmacology, and public health experts. The presence of burrows containing adult female mites, their eggs, and excreta is the diagnostic hallmark of scabies. Definitive diagnosis typically involves direct microscopic examination of skin scrapings obtained from these burrows, although dermoscopy has become a diagnostic tool in clinical practice. Treatment modalities encompass topical agents, such as permethrin, balsam of Peru, precipitated sulfur, and benzyl benzoate. In cases where topical therapy proves inadequate or in instances of crusted scabies, oral ivermectin is recommended as a systemic treatment option. This comprehensive approach addresses the diagnostic and therapeutic challenges associated with scabies, optimizing patient care, and management outcomes. [ABSTRACT FROM AUTHOR]

Introduction: Rosacea is a chronic inflammatory dermatosis that causes facial erythema, papules, and pustules in the centrofacial area. Rosacea may initiate dysfunction of the endothelial cells, which is an early predictor of atherosclerosis, by causing systemic inflammatory changes. In this study, we investigated the potential relationship between rosacea and subclinical atherosclerosis. Method: Fourteen rosacea patients and 14 age- and gender-matched healthy volunteers were included in this study. Patients with known cardiovascular disease and pregnant women were excluded. Demographic data, alcohol consumption, smoking history, physical activity frequency, family history of cardiovascular disease, and anthropometric measurements were recorded. Systolic and diastolic blood pressures were measured, and total cholesterol, high-density lipoprotein, low-density lipoprotein, and triglyceride levels were assessed. The Framingham risk score for coronary heart disease was calculated for all participants. Carotid intimamedia thickness and flow velocity measurements for both common carotid arteries (CCAs) were performed ultrasonographically by the same radiologist. Results: Fourteen rosacea patients (11 females, 3 males; mean age 48.86) and fourteen controls (11 females, 3 males; mean age 41.64) were included. There was no significant difference in mean body mass index (p>0.05). Alcohol consumption was significantly more prevalent in the control group (p=0.029). Family history of cardiovascular disease was significantly more prevalent in rosacea patients (p=0.008). Rosacea patients had significantly higher triglyceride levels (p=0.031). The levels of systolic and diastolic blood pressure were significantly higher in rosacea patients (p=0.039). Blood flow velocities of the right CCA of patients with rosacea were significantly lower (p=0.027). Conclusion: Our study showed that patients with rosacea have higher triglycerides, systolic and diastolic blood pressure levels, and lower right CCA blood flow velocity compared with the general population. A larger sample size is required to increase the precision of the results. [ABSTRACT FROM AUTHOR]